Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 146 | 2024 | 2430 | 16.130 |
Why?
|
Breast Neoplasms | 244 | 2024 | 21019 | 10.770 |
Why?
|
Breast | 75 | 2023 | 1967 | 7.720 |
Why?
|
Ultrasonography, Mammary | 25 | 2021 | 239 | 5.720 |
Why?
|
Early Detection of Cancer | 72 | 2024 | 3201 | 4.540 |
Why?
|
Magnetic Resonance Imaging | 102 | 2023 | 36426 | 3.900 |
Why?
|
Mass Screening | 55 | 2022 | 5429 | 3.440 |
Why?
|
Carcinoma, Ductal, Breast | 22 | 2021 | 1085 | 2.770 |
Why?
|
Image Interpretation, Computer-Assisted | 28 | 2021 | 3359 | 2.680 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 20 | 2022 | 926 | 2.640 |
Why?
|
Diffusion Magnetic Resonance Imaging | 23 | 2019 | 2791 | 2.090 |
Why?
|
Breast Diseases | 11 | 2014 | 442 | 2.070 |
Why?
|
Image Enhancement | 24 | 2021 | 2884 | 1.990 |
Why?
|
Biopsy, Needle | 17 | 2022 | 1626 | 1.900 |
Why?
|
Radiographic Image Enhancement | 6 | 2019 | 876 | 1.830 |
Why?
|
Sensitivity and Specificity | 71 | 2021 | 14665 | 1.710 |
Why?
|
Biopsy | 39 | 2020 | 6766 | 1.510 |
Why?
|
Contrast Media | 31 | 2021 | 5307 | 1.450 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2019 | 1222 | 1.420 |
Why?
|
Artificial Intelligence | 11 | 2023 | 2578 | 1.360 |
Why?
|
Gadolinium DTPA | 16 | 2015 | 823 | 1.350 |
Why?
|
Carcinoma in Situ | 11 | 2019 | 791 | 1.280 |
Why?
|
Female | 248 | 2024 | 392705 | 1.230 |
Why?
|
Fiducial Markers | 2 | 2020 | 132 | 1.230 |
Why?
|
Radiology | 19 | 2021 | 2113 | 1.210 |
Why?
|
Middle Aged | 169 | 2024 | 220921 | 1.110 |
Why?
|
Benchmarking | 6 | 2018 | 1045 | 1.030 |
Why?
|
Aged | 131 | 2024 | 169310 | 1.010 |
Why?
|
Lymph Nodes | 7 | 2021 | 3465 | 0.990 |
Why?
|
Preoperative Care | 9 | 2021 | 2242 | 0.980 |
Why?
|
Humans | 277 | 2024 | 761596 | 0.950 |
Why?
|
Radiography, Interventional | 3 | 2020 | 1121 | 0.910 |
Why?
|
Retrospective Studies | 72 | 2024 | 80647 | 0.890 |
Why?
|
Reproducibility of Results | 45 | 2021 | 20100 | 0.880 |
Why?
|
Adult | 141 | 2024 | 221210 | 0.880 |
Why?
|
Practice Guidelines as Topic | 15 | 2020 | 7391 | 0.850 |
Why?
|
Palpation | 7 | 2016 | 166 | 0.830 |
Why?
|
Aged, 80 and over | 54 | 2021 | 58984 | 0.780 |
Why?
|
Stereotaxic Techniques | 5 | 2010 | 555 | 0.750 |
Why?
|
Diagnosis, Differential | 27 | 2021 | 12973 | 0.750 |
Why?
|
Axilla | 9 | 2024 | 624 | 0.740 |
Why?
|
Sentinel Lymph Node Biopsy | 4 | 2014 | 732 | 0.680 |
Why?
|
Unnecessary Procedures | 3 | 2017 | 415 | 0.650 |
Why?
|
Registries | 20 | 2019 | 8225 | 0.640 |
Why?
|
Risk Assessment | 27 | 2024 | 23996 | 0.620 |
Why?
|
Medical Oncology | 7 | 2021 | 2321 | 0.610 |
Why?
|
Ultrasonography, Interventional | 3 | 2018 | 1496 | 0.590 |
Why?
|
Health Literacy | 2 | 2021 | 444 | 0.590 |
Why?
|
Delayed Diagnosis | 2 | 2021 | 463 | 0.590 |
Why?
|
Wireless Technology | 1 | 2018 | 98 | 0.590 |
Why?
|
Needles | 3 | 2018 | 451 | 0.580 |
Why?
|
Healthcare Disparities | 4 | 2021 | 3358 | 0.580 |
Why?
|
Predictive Value of Tests | 27 | 2018 | 15266 | 0.580 |
Why?
|
Mastectomy | 6 | 2022 | 1822 | 0.570 |
Why?
|
Utilization Review | 1 | 2018 | 382 | 0.550 |
Why?
|
ROC Curve | 14 | 2024 | 3578 | 0.540 |
Why?
|
False Positive Reactions | 11 | 2019 | 957 | 0.530 |
Why?
|
Neoplasm Invasiveness | 13 | 2020 | 3597 | 0.510 |
Why?
|
Magnetics | 1 | 2018 | 599 | 0.500 |
Why?
|
Algorithms | 10 | 2020 | 14033 | 0.500 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2014 | 101 | 0.490 |
Why?
|
Biopsy, Fine-Needle | 3 | 2018 | 1118 | 0.480 |
Why?
|
Allied Health Personnel | 1 | 2016 | 155 | 0.480 |
Why?
|
Imaging, Three-Dimensional | 8 | 2018 | 4062 | 0.470 |
Why?
|
United States | 45 | 2024 | 72340 | 0.460 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 203 | 0.450 |
Why?
|
Neoadjuvant Therapy | 9 | 2024 | 2828 | 0.430 |
Why?
|
Population Surveillance | 5 | 2016 | 2598 | 0.420 |
Why?
|
Surgery, Computer-Assisted | 3 | 2009 | 1007 | 0.420 |
Why?
|
Diagnostic Imaging | 6 | 2021 | 3530 | 0.410 |
Why?
|
Vacuum | 6 | 2010 | 65 | 0.410 |
Why?
|
Patient-Centered Care | 2 | 2013 | 1421 | 0.410 |
Why?
|
Area Under Curve | 7 | 2014 | 1638 | 0.410 |
Why?
|
Triage | 1 | 2019 | 986 | 0.400 |
Why?
|
Breast Cyst | 1 | 2011 | 8 | 0.400 |
Why?
|
Clinical Competence | 4 | 2016 | 4793 | 0.390 |
Why?
|
Hyperplasia | 4 | 2011 | 1152 | 0.380 |
Why?
|
Washington | 9 | 2017 | 315 | 0.380 |
Why?
|
Neoplasm Staging | 20 | 2019 | 11120 | 0.380 |
Why?
|
Diagnostic Errors | 4 | 2013 | 1265 | 0.370 |
Why?
|
Neoplasms, Second Primary | 5 | 2020 | 1052 | 0.370 |
Why?
|
Chi-Square Distribution | 8 | 2012 | 3415 | 0.370 |
Why?
|
Lymphatic Metastasis | 7 | 2020 | 2915 | 0.370 |
Why?
|
Evidence-Based Medicine | 8 | 2016 | 3688 | 0.360 |
Why?
|
Logistic Models | 13 | 2022 | 13255 | 0.360 |
Why?
|
Risk Factors | 34 | 2024 | 74213 | 0.360 |
Why?
|
Precancerous Conditions | 1 | 2017 | 980 | 0.360 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2012 | 187 | 0.360 |
Why?
|
Community Health Services | 2 | 2008 | 656 | 0.350 |
Why?
|
Professional Competence | 1 | 2013 | 431 | 0.340 |
Why?
|
Behavioral Risk Factor Surveillance System | 3 | 2020 | 209 | 0.330 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2010 | 592 | 0.310 |
Why?
|
Educational Measurement | 2 | 2013 | 1255 | 0.300 |
Why?
|
Lymph Node Excision | 2 | 2012 | 1271 | 0.300 |
Why?
|
Ambulatory Care | 1 | 2019 | 2775 | 0.300 |
Why?
|
Observer Variation | 5 | 2016 | 2606 | 0.300 |
Why?
|
Disclosure | 1 | 2013 | 748 | 0.300 |
Why?
|
Carcinoma, Lobular | 5 | 2018 | 481 | 0.290 |
Why?
|
Surgical Instruments | 1 | 2009 | 383 | 0.280 |
Why?
|
Receptors, Progesterone | 5 | 2024 | 1129 | 0.280 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2022 | 9001 | 0.280 |
Why?
|
Insurance, Health | 1 | 2019 | 2499 | 0.270 |
Why?
|
Prospective Studies | 25 | 2024 | 54423 | 0.270 |
Why?
|
Kinetics | 4 | 2019 | 6374 | 0.260 |
Why?
|
Young Adult | 17 | 2021 | 59260 | 0.260 |
Why?
|
Genes, BRCA2 | 3 | 2020 | 601 | 0.260 |
Why?
|
Program Evaluation | 3 | 2019 | 2495 | 0.260 |
Why?
|
Referral and Consultation | 1 | 2019 | 3600 | 0.260 |
Why?
|
Carcinoma | 1 | 2017 | 2330 | 0.260 |
Why?
|
Artifacts | 2 | 2013 | 1911 | 0.250 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2021 | 3514 | 0.240 |
Why?
|
Watchful Waiting | 2 | 2020 | 491 | 0.240 |
Why?
|
Needs Assessment | 3 | 2019 | 1139 | 0.240 |
Why?
|
Receptors, Estrogen | 6 | 2024 | 2209 | 0.240 |
Why?
|
Age Factors | 15 | 2019 | 18399 | 0.230 |
Why?
|
Developing Countries | 5 | 2016 | 2885 | 0.230 |
Why?
|
Uganda | 4 | 2017 | 1332 | 0.230 |
Why?
|
Radiology Department, Hospital | 1 | 2008 | 406 | 0.230 |
Why?
|
Guideline Adherence | 3 | 2019 | 2220 | 0.220 |
Why?
|
Receptor, erbB-3 | 1 | 2024 | 143 | 0.220 |
Why?
|
Cohort Studies | 16 | 2022 | 41495 | 0.210 |
Why?
|
Quality Assurance, Health Care | 2 | 2013 | 2169 | 0.210 |
Why?
|
Physical Examination | 6 | 2019 | 1255 | 0.210 |
Why?
|
Clinical Trials as Topic | 9 | 2021 | 8002 | 0.210 |
Why?
|
Breast Self-Examination | 5 | 2017 | 33 | 0.210 |
Why?
|
Incidence | 9 | 2024 | 21355 | 0.200 |
Why?
|
Radiology, Interventional | 1 | 2006 | 476 | 0.200 |
Why?
|
Architectural Accessibility | 1 | 2021 | 24 | 0.200 |
Why?
|
Societies, Medical | 4 | 2018 | 3905 | 0.190 |
Why?
|
Tobacco Use Cessation | 2 | 2020 | 94 | 0.190 |
Why?
|
Blood Component Removal | 2 | 2002 | 132 | 0.190 |
Why?
|
Receptor, erbB-2 | 5 | 2024 | 2557 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2018 | 4016 | 0.190 |
Why?
|
Feasibility Studies | 4 | 2024 | 5247 | 0.190 |
Why?
|
Collagen | 1 | 2009 | 2638 | 0.190 |
Why?
|
Age Distribution | 4 | 2017 | 2879 | 0.180 |
Why?
|
Prognosis | 11 | 2022 | 29629 | 0.180 |
Why?
|
Confidence Intervals | 3 | 2019 | 2927 | 0.180 |
Why?
|
Patient Compliance | 3 | 2024 | 2690 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 3 | 2020 | 3206 | 0.180 |
Why?
|
Appointments and Schedules | 1 | 2024 | 443 | 0.170 |
Why?
|
Positron-Emission Tomography | 6 | 2024 | 6484 | 0.170 |
Why?
|
Time | 1 | 2021 | 546 | 0.170 |
Why?
|
Terminology as Topic | 2 | 2010 | 1530 | 0.160 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39106 | 0.160 |
Why?
|
Health Services Accessibility | 4 | 2019 | 5440 | 0.160 |
Why?
|
Neoplasm, Residual | 5 | 2018 | 1008 | 0.160 |
Why?
|
False Negative Reactions | 2 | 2018 | 573 | 0.160 |
Why?
|
Vaccination | 2 | 2021 | 3384 | 0.160 |
Why?
|
Search Engine | 1 | 2019 | 143 | 0.150 |
Why?
|
Breast Neoplasms, Male | 1 | 2020 | 219 | 0.150 |
Why?
|
Prevalence | 6 | 2016 | 15733 | 0.150 |
Why?
|
Comprehension | 2 | 2021 | 621 | 0.150 |
Why?
|
Nasopharynx | 1 | 2020 | 401 | 0.150 |
Why?
|
Radiology Information Systems | 1 | 2002 | 529 | 0.150 |
Why?
|
SEER Program | 4 | 2019 | 1450 | 0.150 |
Why?
|
Insurance Coverage | 2 | 2019 | 1940 | 0.140 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2022 | 3769 | 0.140 |
Why?
|
Antigens, CD34 | 2 | 2002 | 658 | 0.140 |
Why?
|
Blood Specimen Collection | 1 | 1998 | 238 | 0.140 |
Why?
|
Time Factors | 11 | 2024 | 39969 | 0.140 |
Why?
|
Reference Values | 4 | 2019 | 4920 | 0.140 |
Why?
|
Truth Disclosure | 2 | 2012 | 434 | 0.140 |
Why?
|
Feedback | 1 | 2020 | 791 | 0.140 |
Why?
|
Health Facilities | 3 | 2018 | 580 | 0.130 |
Why?
|
Anisotropy | 2 | 2010 | 1283 | 0.130 |
Why?
|
Saliva | 1 | 2020 | 828 | 0.130 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 392 | 0.130 |
Why?
|
Lidocaine | 2 | 1999 | 538 | 0.130 |
Why?
|
Reading | 1 | 2019 | 531 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2013 | 710 | 0.130 |
Why?
|
Physician's Role | 2 | 2013 | 917 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2021 | 13381 | 0.130 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2017 | 9280 | 0.130 |
Why?
|
Chorda Tympani Nerve | 1 | 1995 | 11 | 0.130 |
Why?
|
Taste Buds | 1 | 1995 | 24 | 0.130 |
Why?
|
Ultrasonography | 3 | 2021 | 5971 | 0.130 |
Why?
|
Eligibility Determination | 1 | 2019 | 421 | 0.130 |
Why?
|
Radiopharmaceuticals | 4 | 2017 | 2650 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2017 | 2009 | 0.120 |
Why?
|
Hydrogels | 1 | 2020 | 720 | 0.120 |
Why?
|
Equipment Design | 2 | 2018 | 3511 | 0.120 |
Why?
|
Choline | 1 | 2016 | 515 | 0.120 |
Why?
|
Genes, BRCA1 | 2 | 2009 | 764 | 0.120 |
Why?
|
Adolescent | 13 | 2019 | 88326 | 0.120 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 1995 | 192 | 0.120 |
Why?
|
Radiography | 2 | 2021 | 6965 | 0.110 |
Why?
|
Menstrual Cycle | 2 | 2013 | 539 | 0.110 |
Why?
|
Multivariate Analysis | 6 | 2019 | 12059 | 0.110 |
Why?
|
Radiation Oncology | 1 | 2020 | 563 | 0.110 |
Why?
|
Taste | 1 | 1995 | 189 | 0.110 |
Why?
|
Patient Care Planning | 2 | 2016 | 909 | 0.110 |
Why?
|
Trisomy | 1 | 1995 | 260 | 0.110 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2079 | 0.110 |
Why?
|
Pandemics | 3 | 2021 | 8656 | 0.110 |
Why?
|
Cell Separation | 1 | 1998 | 1720 | 0.110 |
Why?
|
Evaluation Studies as Topic | 1 | 2015 | 1625 | 0.100 |
Why?
|
Health Services Misuse | 1 | 2014 | 244 | 0.100 |
Why?
|
Patient Access to Records | 1 | 2013 | 119 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1112 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2846 | 0.100 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2850 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2019 | 623 | 0.100 |
Why?
|
Patient Education as Topic | 2 | 2021 | 2319 | 0.100 |
Why?
|
Equipment Safety | 1 | 2013 | 249 | 0.100 |
Why?
|
Photomicrography | 1 | 2011 | 71 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2015 | 11742 | 0.100 |
Why?
|
Data Mining | 1 | 2016 | 551 | 0.100 |
Why?
|
Lithotripsy, Laser | 1 | 1991 | 44 | 0.100 |
Why?
|
Mandatory Reporting | 1 | 2012 | 123 | 0.090 |
Why?
|
Multicenter Studies as Topic | 3 | 2011 | 1702 | 0.090 |
Why?
|
Phantoms, Imaging | 3 | 2011 | 2526 | 0.090 |
Why?
|
Internet | 2 | 2021 | 3093 | 0.090 |
Why?
|
Software | 3 | 2013 | 4434 | 0.090 |
Why?
|
Women's Health | 2 | 2013 | 2065 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1445 | 0.090 |
Why?
|
Lithotripsy | 1 | 1991 | 140 | 0.090 |
Why?
|
Metabolic Clearance Rate | 1 | 2011 | 361 | 0.090 |
Why?
|
Radio Waves | 1 | 2012 | 251 | 0.090 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 26129 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2016 | 1475 | 0.090 |
Why?
|
Spouses | 1 | 2013 | 283 | 0.090 |
Why?
|
Curriculum | 3 | 2020 | 3743 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 2 | 2002 | 3397 | 0.090 |
Why?
|
Cholelithiasis | 1 | 1991 | 407 | 0.090 |
Why?
|
Gadolinium | 1 | 2015 | 960 | 0.080 |
Why?
|
Vulnerable Populations | 1 | 2015 | 703 | 0.080 |
Why?
|
Carcinoma, Ductal | 2 | 2011 | 97 | 0.080 |
Why?
|
Tumor Burden | 4 | 2018 | 1892 | 0.080 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4915 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5872 | 0.080 |
Why?
|
Oxygen Radioisotopes | 1 | 2008 | 75 | 0.080 |
Why?
|
Odds Ratio | 6 | 2022 | 9647 | 0.080 |
Why?
|
Phytoestrogens | 1 | 2008 | 59 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
Problem Solving | 1 | 2011 | 443 | 0.080 |
Why?
|
Specimen Handling | 2 | 2020 | 702 | 0.080 |
Why?
|
Loss of Heterozygosity | 1 | 2010 | 662 | 0.080 |
Why?
|
Socioeconomic Factors | 5 | 2024 | 7828 | 0.080 |
Why?
|
Nerve Block | 1 | 1995 | 706 | 0.080 |
Why?
|
Computer Simulation | 2 | 2019 | 6241 | 0.080 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1436 | 0.080 |
Why?
|
Smoking Cessation | 1 | 2020 | 2057 | 0.070 |
Why?
|
Attitude to Health | 1 | 2017 | 2025 | 0.070 |
Why?
|
Isoflavones | 1 | 2008 | 136 | 0.070 |
Why?
|
Absorptiometry, Photon | 1 | 2013 | 1738 | 0.070 |
Why?
|
Fetus | 1 | 1995 | 1863 | 0.070 |
Why?
|
Cost-Benefit Analysis | 3 | 2015 | 5493 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2019 | 20568 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6228 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 17904 | 0.070 |
Why?
|
Stainless Steel | 2 | 2004 | 79 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3725 | 0.070 |
Why?
|
Health Resources | 2 | 2003 | 935 | 0.070 |
Why?
|
Ultrasonography, Prenatal | 1 | 1995 | 1755 | 0.070 |
Why?
|
Likelihood Functions | 1 | 2009 | 992 | 0.070 |
Why?
|
Carcinoma, Medullary | 1 | 2006 | 115 | 0.070 |
Why?
|
Databases, Factual | 2 | 2018 | 7968 | 0.060 |
Why?
|
Case-Control Studies | 5 | 2018 | 22176 | 0.060 |
Why?
|
Incidental Findings | 1 | 2011 | 697 | 0.060 |
Why?
|
Probability | 1 | 2011 | 2477 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3929 | 0.060 |
Why?
|
Informed Consent | 1 | 2012 | 1008 | 0.060 |
Why?
|
Pilot Projects | 2 | 2010 | 8633 | 0.060 |
Why?
|
Risk | 3 | 2020 | 9610 | 0.060 |
Why?
|
Models, Statistical | 3 | 2011 | 5079 | 0.060 |
Why?
|
Laser Therapy | 1 | 1991 | 1092 | 0.060 |
Why?
|
Immunohistochemistry | 2 | 2024 | 11076 | 0.060 |
Why?
|
Radiation Injuries | 1 | 2012 | 1189 | 0.060 |
Why?
|
Computer-Assisted Instruction | 1 | 2007 | 362 | 0.060 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2020 | 297 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9319 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2013 | 1998 | 0.050 |
Why?
|
Health Promotion | 1 | 2015 | 2214 | 0.050 |
Why?
|
Medical Errors | 1 | 2012 | 1263 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10212 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2010 | 2426 | 0.050 |
Why?
|
Calcinosis | 2 | 2010 | 1469 | 0.050 |
Why?
|
Health Planning Guidelines | 1 | 2003 | 151 | 0.050 |
Why?
|
Testosterone | 1 | 2013 | 2472 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4591 | 0.050 |
Why?
|
Survivors | 1 | 2013 | 2371 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2007 | 823 | 0.050 |
Why?
|
Turkeys | 1 | 2001 | 45 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6845 | 0.050 |
Why?
|
Patient Selection | 2 | 2013 | 4244 | 0.050 |
Why?
|
Regression Analysis | 3 | 2019 | 6345 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2006 | 1186 | 0.050 |
Why?
|
Physician-Patient Relations | 2 | 2012 | 3251 | 0.050 |
Why?
|
Ukraine | 1 | 2001 | 149 | 0.050 |
Why?
|
Titanium | 1 | 2003 | 485 | 0.040 |
Why?
|
Community Health Centers | 1 | 2024 | 461 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5882 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2021 | 64685 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13367 | 0.040 |
Why?
|
Teaching | 1 | 2007 | 1170 | 0.040 |
Why?
|
Taiwan | 1 | 2021 | 521 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2011 | 3313 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2021 | 453 | 0.040 |
Why?
|
Mastectomy, Segmental | 2 | 2019 | 955 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4811 | 0.040 |
Why?
|
Genetic Testing | 2 | 2009 | 3537 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2015 | 6815 | 0.040 |
Why?
|
Puerto Rico | 1 | 2020 | 376 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22173 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2645 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1379 | 0.040 |
Why?
|
Medical Records | 1 | 2003 | 1408 | 0.040 |
Why?
|
Proprioception | 1 | 1999 | 133 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14608 | 0.040 |
Why?
|
Accreditation | 1 | 2020 | 473 | 0.040 |
Why?
|
Premenopause | 1 | 2021 | 1039 | 0.040 |
Why?
|
Obesity | 1 | 2019 | 12947 | 0.030 |
Why?
|
Exercise | 1 | 2013 | 5890 | 0.030 |
Why?
|
Universities | 1 | 2021 | 993 | 0.030 |
Why?
|
Breast Implants | 1 | 2000 | 411 | 0.030 |
Why?
|
Taste Threshold | 1 | 1995 | 7 | 0.030 |
Why?
|
Glossopharyngeal Nerve | 1 | 1995 | 18 | 0.030 |
Why?
|
Health Communication | 1 | 2018 | 213 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30053 | 0.030 |
Why?
|
Male | 10 | 2020 | 360846 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 787 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 629 | 0.030 |
Why?
|
Leukocyte Count | 1 | 1998 | 1596 | 0.030 |
Why?
|
Sentinel Surveillance | 1 | 2016 | 291 | 0.030 |
Why?
|
Cell Count | 1 | 1998 | 1835 | 0.030 |
Why?
|
North Carolina | 1 | 2015 | 325 | 0.030 |
Why?
|
Pregnancy, High-Risk | 1 | 1995 | 122 | 0.030 |
Why?
|
Cost Control | 1 | 2016 | 628 | 0.030 |
Why?
|
Afferent Pathways | 1 | 1995 | 298 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2015 | 246 | 0.030 |
Why?
|
Culture | 1 | 2017 | 623 | 0.030 |
Why?
|
Rupture | 1 | 1995 | 443 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 931 | 0.030 |
Why?
|
Awareness | 1 | 2017 | 648 | 0.030 |
Why?
|
Catheter Ablation | 1 | 2006 | 2751 | 0.030 |
Why?
|
Karyotyping | 1 | 1995 | 1171 | 0.030 |
Why?
|
Intention | 1 | 2015 | 347 | 0.030 |
Why?
|
Fear | 1 | 2021 | 1477 | 0.030 |
Why?
|
Postmenopause | 1 | 2021 | 2513 | 0.030 |
Why?
|
Body Mass Index | 2 | 2021 | 12953 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 818 | 0.030 |
Why?
|
Language | 1 | 2021 | 1543 | 0.020 |
Why?
|
Pedigree | 1 | 2020 | 4542 | 0.020 |
Why?
|
X-Ray Film | 1 | 2011 | 31 | 0.020 |
Why?
|
Tongue | 1 | 1995 | 403 | 0.020 |
Why?
|
Health Care Costs | 2 | 2016 | 3242 | 0.020 |
Why?
|
Shoulder Joint | 1 | 1999 | 742 | 0.020 |
Why?
|
Maternal Age | 1 | 1995 | 809 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3332 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6345 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2015 | 647 | 0.020 |
Why?
|
Receptors, Steroid | 1 | 2011 | 156 | 0.020 |
Why?
|
Neural Inhibition | 1 | 1995 | 590 | 0.020 |
Why?
|
Cadaver | 1 | 1995 | 1358 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 832 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2016 | 997 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 815 | 0.020 |
Why?
|
Anthracyclines | 1 | 2011 | 284 | 0.020 |
Why?
|
Diffusion | 1 | 2011 | 814 | 0.020 |
Why?
|
Hydroxyestrones | 1 | 2008 | 17 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4061 | 0.020 |
Why?
|
Soy Foods | 1 | 2008 | 44 | 0.020 |
Why?
|
Taxoids | 1 | 2011 | 668 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2373 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8554 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1722 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8527 | 0.020 |
Why?
|
Family Health | 1 | 2013 | 1257 | 0.020 |
Why?
|
Minority Groups | 1 | 2015 | 1203 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2008 | 353 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2522 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1175 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2008 | 13642 | 0.020 |
Why?
|
Focus Groups | 1 | 2013 | 1415 | 0.020 |
Why?
|
World Health Organization | 2 | 2003 | 1322 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4573 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 2004 | 0.020 |
Why?
|
Estrogens | 1 | 2013 | 1522 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2011 | 709 | 0.020 |
Why?
|
Exercise Test | 1 | 2013 | 2127 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8833 | 0.020 |
Why?
|
Medicaid | 1 | 2019 | 2818 | 0.020 |
Why?
|
Phenotype | 2 | 2017 | 16592 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2003 | 5337 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 1371 | 0.010 |
Why?
|
Rural Population | 1 | 2015 | 2287 | 0.010 |
Why?
|
Malpractice | 1 | 2009 | 556 | 0.010 |
Why?
|
Menopause | 1 | 2011 | 1646 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 15936 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2008 | 803 | 0.010 |
Why?
|
Health Expenditures | 1 | 2015 | 2366 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1784 | 0.010 |
Why?
|
Patient Rights | 1 | 2003 | 125 | 0.010 |
Why?
|
Child | 1 | 2010 | 80158 | 0.010 |
Why?
|
Water | 1 | 2008 | 1411 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6484 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7879 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23447 | 0.010 |
Why?
|
Blood Cell Count | 1 | 2002 | 397 | 0.010 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2002 | 225 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3322 | 0.010 |
Why?
|
Pathology | 1 | 2003 | 270 | 0.010 |
Why?
|
Health Care Rationing | 1 | 2003 | 437 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8466 | 0.010 |
Why?
|
Medical History Taking | 1 | 2003 | 774 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2002 | 629 | 0.010 |
Why?
|
Follicular Phase | 1 | 1998 | 143 | 0.010 |
Why?
|
Luteal Phase | 1 | 1998 | 138 | 0.010 |
Why?
|
Mammaplasty | 1 | 2008 | 1239 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2006 | 2330 | 0.010 |
Why?
|
Injections, Intra-Articular | 1 | 1999 | 280 | 0.010 |
Why?
|
Medicare | 1 | 2015 | 6770 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12463 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2004 | 1779 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9420 | 0.010 |
Why?
|
Communication | 1 | 2009 | 3875 | 0.010 |
Why?
|
Pregnancy | 1 | 1995 | 29890 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 1999 | 1588 | 0.010 |
Why?
|
Public Health | 1 | 2003 | 2669 | 0.010 |
Why?
|
Animals | 1 | 2001 | 168475 | 0.010 |
Why?
|
Brain | 1 | 2016 | 27121 | 0.000 |
Why?
|
Survival Rate | 1 | 2003 | 12723 | 0.000 |
Why?
|